United Services Automobile Association purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 5,269 shares of the company's stock, valued at approximately $719,000.
Several other large investors have also recently bought and sold shares of the business. Pinnacle Bancorp Inc. raised its position in Cardinal Health by 11.2% in the first quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock worth $106,000 after acquiring an additional 77 shares in the last quarter. Applied Finance Capital Management LLC increased its position in shares of Cardinal Health by 1.4% in the first quarter. Applied Finance Capital Management LLC now owns 6,049 shares of the company's stock valued at $833,000 after buying an additional 85 shares in the last quarter. CSS LLC IL increased its position in shares of Cardinal Health by 0.8% in the fourth quarter. CSS LLC IL now owns 11,190 shares of the company's stock valued at $1,323,000 after buying an additional 90 shares in the last quarter. Perigon Wealth Management LLC increased its position in shares of Cardinal Health by 4.2% in the first quarter. Perigon Wealth Management LLC now owns 2,242 shares of the company's stock valued at $309,000 after buying an additional 90 shares in the last quarter. Finally, Smith Shellnut Wilson LLC ADV increased its position in shares of Cardinal Health by 2.1% in the first quarter. Smith Shellnut Wilson LLC ADV now owns 4,399 shares of the company's stock valued at $606,000 after buying an additional 91 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.
Cardinal Health Trading Down 0.1%
CAH traded down $0.14 during midday trading on Friday, hitting $152.34. The company's stock had a trading volume of 1,162,569 shares, compared to its average volume of 2,177,648. The firm has a market cap of $36.38 billion, a P/E ratio of 23.62, a PEG ratio of 1.29 and a beta of 0.73. The firm has a 50-day moving average price of $154.50 and a two-hundred day moving average price of $147.65. Cardinal Health, Inc. has a 52-week low of $106.54 and a 52-week high of $168.44.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm's revenue was up .5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health's payout ratio is 31.63%.
Insider Buying and Selling
In other news, insider Ola M. Snow sold 28,151 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares in the company, valued at approximately $2,298,293.14. The trade was a 64.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michelle D. Greene sold 13,500 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the sale, the insider owned 14,976 shares of the company's stock, valued at $2,228,728.32. The trade was a 47.41% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock worth $40,489,525 over the last ninety days. Insiders own 0.09% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on CAH. Leerink Partners dropped their price target on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research report on Tuesday, August 12th. Bank of America raised their price target on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, June 10th. UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research note on Tuesday, August 12th. Finally, Wall Street Zen lowered Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Eleven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and a consensus target price of $165.93.
Read Our Latest Research Report on Cardinal Health
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report